Skip to content

A Novel Nano Hydrogel Therapy for Faster Healing of Diabetic Wounds

Nano selenium and hybrid polymer incorporated nano hydrogel for Rapid diabetic wound healing activity - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105912
Enrollment
60
Registered
2026-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E08-E13- Diabetes mellitus

Interventions

Intervention1: Nil: Nil

Sponsors

Saveetha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 and 75 years Confirmed diagnosis of Type 2 Diabetes Mellitus Presence of a chronic diabetic foot ulcer of duration greater than 4 weeks Wagner Grade I or II diabetic foot ulcers Ulcer size measuring 1 to 10 cm2 at baseline assessment HbA1c less than or equal to 12 percent indicating manageable glycemic status

Exclusion criteria

Exclusion criteria: Wagner Grade III to V ulcers including deep infection gangrene or osteomyelitis Non diabetic ulcers including venous arterial traumatic or malignant ulcers Severe peripheral arterial disease defined as Ankle Brachial Index less than 0.8 Active systemic infection or sepsis Known allergy to selenium or any hydrogel components Chronic kidney disease stage IV or V

Design outcomes

Primary

MeasureTime frame
Percentage reduction in wound areaTimepoint: Day 0 Week 2 Week 4 Week 8 and Week 12

Secondary

MeasureTime frame
Rate of wound contraction assessed at Week 2 Week 4 Week 8 and Week 12 Change in wound infection status assessed at baseline and each follow up visit Pain score using Visual Analog Scale assessed at baseline Week 2 Week 4 Week 8 and Week 12 Glycemic control assessed using HbA1c at baseline and Week 12 Inflammatory markers assessed at baseline and Week 12 Safety assessment including local irritation allergy or adverse reactions assessed at every visitTimepoint: Day 0 Week 2 Week 4 Week 8 and Week 12

Countries

India

Contacts

Public ContactDR S NIMITHAP

SAVEETHA MEDICAL COLLEGE AND HOSPITAL

ananthakumarpk@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026